Latest filing published 18 May 2009 for SCICLONE PHARMACEUTICALS INC, €11k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Rolf H. Henel: trading record in brief
Rolf H. Henel discloses dealings in 2 companies, chiefly Sciclone Pharmaceuticals Inc and Penwest Pharmaceuticals Co. The record holds 23 filings, for trades running from 15 November 2006 to 14 May 2009.
On the open market, the record shows 12 purchases worth €61k and 5 sales worth €13k. On balance, insiders were net buyers of €47k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise.
The median purchase comes to €5,802.
Most recently, on 18 May 2009, the filings show an option exercise worth €11k in Sciclone Pharmaceuticals Inc. The latest purchase dates back some time: it was published 6,752 days ago, on 15 May 2008. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Rolf H. Henel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.44Common StockSEC:0000880771-09-000002:0
- 4,300 shares@ US$1.75Common StockSEC:0000880771-08-000002:0Canonical exit: 11 Aug 2008 (T+90)
- 5,000 shares@ US$1.75Common StockSEC:0000880771-08-000002:1Canonical exit: 11 Aug 2008 (T+90)
- 5,000 shares@ US$1.80Common StockSEC:0000880771-08-000002:2Canonical exit: 11 Aug 2008 (T+90)
- 5,100 shares@ US$1.80Common StockSEC:0000880771-08-000002:3Canonical exit: 11 Aug 2008 (T+90)
- 5,000 shares@ US$1.79Common StockSEC:0000880771-08-000002:4Canonical exit: 11 Aug 2008 (T+90)
- 5,000 shares@ US$1.80Common StockSEC:0000880771-08-000002:7Canonical exit: 12 Aug 2008 (T+90)
- 1,600 shares@ US$2.04Common StockSEC:0001250023-08-000003:5
- 500 shares@ US$2.04Common StockSEC:0001250023-08-000003:6
- 300 shares@ US$2.26Common StockSEC:0001250023-08-000003:0Canonical exit: 27 Mar 2008 (T+90)
- 9,100 shares@ US$2.27Common StockSEC:0001250023-08-000003:1Canonical exit: 27 Mar 2008 (T+90)
- 2,334 shares@ US$2.15Common StockSEC:0001250023-08-000003:2
- 1,398 shares@ US$2.12Common StockSEC:0001250023-08-000003:3
- 3,568 shares@ US$2.03Common StockSEC:0001250023-08-000003:4
- 100 shares@ US$1.81Common StockSEC:0001250023-07-000038:0Canonical exit: 18 Feb 2008 (T+90)
- 500 shares@ US$1.85Common StockSEC:0001250023-07-000038:1Canonical exit: 21 Feb 2008 (T+90)
- 12,000 shares0Common StockSEC:0001209191-07-025149:0
- 5,000 shares@ US$16.74Common StockSEC:0001209191-06-060126:0
- 2,500 shares@ US$17.16Common StockSEC:0001209191-06-060126:1
- 3,448 shares@ US$17.58Common stockSEC:0001209191-06-060211:0
- 302 shares@ US$17.59Common StockSEC:0001209191-06-060211:1
21 of 21 declarations
